|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.00 / 0.00|
Economists expect small increase in jobless claims, new record in continuing claims
Movers roundup: Hospira rise continues on cost-cutting plans, CB Richard Ellis leaps
Hospira shares extend gains on plan to cut jobs, restructure bid to reduce costs
Hospira, Carnival, Walt Disney, Blue Nile, H&R Block are among big market movers Tuesday
Warner Chilcott says it sued Impax over generic 150 mg Doryx, triggering stay of FDA ruling
Warner Chilcott says FDA won't delay rulings on 2 strengths of Doryx, but may halt a third
Warner Chilcott faces new patent dispute over Doryx with Impax Laboratories
Jonathan Moreland, author of Insider Insights, gives you the lowdown on top stock purchases and sales.
Cramer thinks highly of Hospira, which makes generic drugs that are ready to use in disposable syringes.
The crew's Guy Adami likes the company's big order backlog.
Hospira, James Hardie upgraded; Sunoco, Coach, Centex downgraded.
Bernanke helps stocks mount a tepid recover. Eaton Vance's Duncan Richardson says opportunity calls.
The hospital group's members will get access to pain-management systems.
Hospira and King Pharmaceuticals tank after their earnings miss forecasts.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.